1World Health Organization (2001) Diet, Physical Activity and Health, . Geneva: WHO.
2Allender, S, Scarborough, P, Peto, V, et al. (editors) (2008) European Cardiovascular Disease Statistics, 2008 Edition. In European Cardiovascular Disease Statistics, p. 112Oxford: University of Oxford.
3Alwan, A (2011) Global Status Report on Noncommunicable Diseases 2010. Geneva: WHO.
4Kreuter, MW & Wray, RJ (2003) Tailored and targeted health communication: strategies for enhancing information relevance. Am J Health Behav 27, S227–S232.
5Marantz, PR (2010) Rethinking dietary guidelines. Crit Rev Food Sci Nutr 50, 17–18.
6Hippisley-Cox, J, Coupland, C, Vinogradova, Y, et al. (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. Br Med J 335, 136.
7Hesketh, J, Wybranska, I, Dommels, Y, et al. (2006) Nutrient–gene interactions in benefit–risk analysis. Br J Nutr 95, 1232–1236.
8National Institutes of Health (2003) NIH News – international consortium completes human genome project: all goals achieved; new vision for genome unveiled. http://www.nih.gov/news/pr/apr2003/nhgri-14.htm (accessed accessed December 2011).
9van Ommen, V (2007) Personalized nutrition from a health perspective: luxury or necessity? Genes Nutr 2, 3–4.
10Kussmann, M, Raymond, F & Affolter, M (2006) OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 124, 758–787.
11Kaput, J & Rodriguez, RL (2004) Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 16, 166–177.
12Ordovas, JM & Mooser, V (2004) Nutrigenomics and nutrigenetics. Curr Opin Lipidol 15, 101–108.
13Mutch, D, Wahli, W & Williamson, G (2005) Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J 19, 1602–1616.
14Dopler Nelson, M, Prabakar, P & Kondragunta, V (2010) Genetic phenotypes predict weight loss success: the right diet does matter. In . San Francisco: American Heart Association.
15Department of Heath (2008) Putting Prevention First – Vascular Checks: Risk Assessment and Management. London: Department of Health.
16Rose, G, Khaw, K & Marmot, M (2008) Rose's Strategy of Preventative Medicine. Oxford: Oxford University Press.
17Simmons, RK, Coleman, RL, Price, HC, et al. (2009) Performance of the UK Prospective Diabetes Study risk engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort. Diabetes Care 32, 708–713.
18Stewart-Knox, BJ, Bunting, BP, Gilpin, S, et al. (2008) Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. Br J Nutr 101, 982–989.
19Makeeva, OA, Markova, VV & Puzyrev, VP (2009) Public interest and expectations concerning commercial genotyping and genetic risk assessment. Pers Med 6, 329–341.
20Aro, AR, Hakonen, A, Hietala, M, et al. (1997) Acceptance of genetic testing in a general population: age, education and gender differences. Patient Educ Couns 32, 41–49.
21Toiviainen, H, Jallinoja, P, Aro, AR, et al. (2003) Medical and lay attitudes towards genetic screening and testing in Finland. Eur J Hum Genet 11, 565–572.
22Sanderson, SC, Wardle, J, Jarvis, MJ, et al. (2004) Public interest in genetic testing for suceptability to heart disease and cancer: a population-based survey in the UK. Prev Med 39, 458–464.
23Morren, M, Rijken, M, Baanders, AN, et al. (2007) Perceived genetic knowledge, attitudes towards genetic testing, and the relationship between these among patients with a chronic disease. Patient Educ Couns 65, 197–204.
24Henneman, L, Timmermans, DRM & Wal, GVD (2006) Public attitudes toward genetic testing: perceived benefits and objections. Genet Test 10, 139–145.
25Morin, K (2009) Knowledge and attitudes of Canadian consumers and health care professionals regarding nutritional genomics. OMICS 13, 37–41.
26Grant, R, Hivert, M, Pandiscio, J, et al. (2009) The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. Diabetologia 52, 2299–2305.
27Antoniou, A, Pharoah, P, Narod, S, et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72, 1117–1130.
29Cherkas, LF, Harris, JM, Levinson, E, et al. (2010) A survey of UK public interest in Internet-based personal genome testing. PLoS One 5, e13473.
30Human Genetics Commission (2003) Genes Direct: Ensuring the Effective Oversight of Genetic Tests Supplied Directly to the Public. London: Department of Health.
31Nielsen, DE & El-Sohemy, A (2012) A randomized trial of genetic information for personalized nutrition. Genes Nutr 7, 559–566.
32Meiser, B, Kasparian, NA, Mitchell, PB, et al. (2008) Attitudes to genetic testing in families with multiple cases of bipolar disorder. Genet Test 12, 233–243.
33Makeeva, OA, Markova, VV, Roses, AD, et al. (2010) An epidemiologic-based survey of public attitudes towards predictive genetic testing in Russia. Pers Med 7, 291–300.
34Adámková, V, Veleminský, M, Zimmelová, P, et al. (2009) Volunteer's willingness to genetic testing – lack of the understanding of the matter. Physiol Res 58, S53–S54.
35Ronteltap, A, van Trijp, JCM & Renes, RJ (2009) Consumer acceptance of nutrigenomics-based personalised nutrition. Br J Nutr 101, 132–144.
36Ronteltap, A, van Trijp, H, Berezowska, A, et al. (2013) Nutrigenomics-based personalised nutritional advice: in search of a business model? Genes Nutr, 8, 153–163.
37Bosompra, K, Flynn, BS, Ashikaga, T, et al. (2000) Likelihood of undergoing genetic testing for cancer risk: a population-based study. Prev Med 30, 155–166.
38Ronteltap, A, Van Trijp, J, Renes, R, et al. (2007) Consumer acceptance of technology-based food innovations: lessons for the future of nutrigenomics. Appetite 49, 1–17.
39World Health Organization (1986) Ottawa Charter for Health Promotion. Geneva: WHO.
40Ronteltap, A & van Trijp, H (2007) Consumer acceptance of personalised nutrition. Genes Nutr 2, 85–87.
41Strecher, VJ, DeVellis, BME, Becker, MH, et al. (1986) The role of self-efficacy in achieving health behavior change. Health Educ Behav 13, 73–92.
42Sanderson, SC, Wardle, J & Humphries, SE (2008) Public health genomics and genetic test evaluation: the challenge of conducting behavioural research on the utility of lifestyle-genetic tests. J Nutrigenet Nutrigenomics 1, 224–234.
43Joost, H, Gibney, M, Cashman, K, et al. (2007) Personalised nutrition: status and perspectives. Br J Nutr 98, 26–31.
44Hunter, DJ, Khoury, MJ & Drazen, JM (2008) Letting the genome out of the bottle – will we get our wish? N Engl J Med 358, 105–107.
45Harvey-Berino, J, Gold, EC, West, DS, et al. (2001) Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation. J Am Diet Assoc 101, 1351–1353.
46McMahon, OC, McConnon, A, McKenzie, K, et al. (2010) An exploration of the use of personalised nutrition among potential end users of the concept. Proc Nutr Soc 69, E357.
47Arakadianos, I, Valdes, AM, Marinos, E, et al. (2007) Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J 6, 29.
48Frosch, DL, Mello, P & Lerman, C (2005) Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev 14, 1485–1489.
49Hogarth, S, Javitt, G & Melzer, D (2008) The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Annu Rev Genomics Hum Genet 9, 161–182.
50Castle, D & Ries, NM (2007) Ethical, legal and social issues in nutrigenomics: the challenges of regulating service delivery and building health professional capacity. Mutat Res 622, 138–143.
51Weir, M, Morin, K, Ries, N, et al. (2010) Canadian health care professionals' knowledge, attitudes and perceptions of nutritional genomics. Br J Nutr 104, 1112–1119.
52Whelan, K, McCarthy, S & Pufulete, M (2008) Genetics and diet–gene interactions: involvement, confidence and knowledge of dietitians. Br J Nutr 99, 23–28.
53Scheuner, MT, Sieverding, P & Shekelle, PG (2008) Delivery of genomic medicine for common chronic adult diseases. J Am Med Assoc 299, 1320–1334.
54van El, CG & Cornel, MC (2011) Genetic testing and common disorders in a public health framework. Eur J Hum Genet 19, 377–381.
55Heshka, JT, Palleschi, C, Howley, H, et al. (2008) A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 10, 19–32.
56Jackson, D, Wills, R, Davies, J, et al. (2009) Public awareness of the symptoms of diabetes mellitus. Diabet Med 8, 971–972.
57Walsh, M & Kuhn, S (2012) Developments in personalised nutrition. Nutr Bull 37, 380–383.
58Mathers, JC (2007) Overview of genes, diet and cancer. Genes Nutr 2, 67–70.
59Barton, P, Andronis, L, Briggs, A, et al. (2011) Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ 343, d4044.